Pre-launch

Infographic: The Clinical Practice Gaps in Precision Medicine

A snapshot of our analysis of the diagnostic challenges and patient journey changes over four years, providing insights to enhance precision medicine commercialization.

Current and anticipated future use of MRD in hematological and solid tumors​

This report explores the current and future use of minimal residual disease (MRD) testing, uncovering adoption trends, clinical applications, and commercial implications.

Addressing the Economic and
Operational Issues of the
Clinical Practice Gaps in NSCLC

This paper presents five key recommendations to tackle economic and operational barriers hindering access to precision medicine for NSCLC patients.

The Clinical Practice Gaps in Precision Medicine

Discover What’s Changed Since the Original 64.4% Insight. The Updated Clinical Practice Gaps Report Is Here.

Practice Gaps Webinar Series

Dive into our series of expert-led webinars, where we break down the seven practice gaps derailing precision medicine and reveal how to overcome them across the patient journey.

The Impact of Clinical Practice Gaps

Our first Practice Gaps study, revealing that 64.4% of patients don't receive the best treatment for them.

ASCO 2025 Highlights: Critical Advancements in Precision Oncology

Rethinking Drug Commercialization: Navigating a Shifting Biotech Investment Landscape

Explore strategies for biotech commercialization amid evolving investment landscapes, focusing on precision and rare disease therapies. Join industry experts in navigating funding challenges and enhancing patient outcomes.

Complexity to Clarity: Using Multi-Modal Data to drive commercial success

Watch our webinar to explore how a multi-modal data approach can simplify complexities in precision medicine and enhance commercialization strategies for better patient outcomes.

Episode 9: The Hematopathology Team: from Slide to Strategy

In ep.9, listen to how Dr. Kuriakose and Dr. Gomez-Gelvez collaborate in hematopathology to enhance patient care and improve treatment strategies in this insightful podcast episode.

Driving Strategic Diagnostic Planning for a Targeted Therapy in Gender-specific Cancer

Drive awareness and adoption of precision therapy for gender-specific cancer through strategic diagnostic planning and tailored solutions from Diaceutics. Unlock your therapy's full potential.

IVDR Impact Analysis Report

Explore the IVDR's impact on diagnostic practices and patient care in the EU, highlighting potential challenges and the need for awareness among stakeholders following the COVID-19 pandemic.

D-Cubed Pharma ROI: The $20B Advantage

Discover how the D-Cubed Model transforms pharma ROI through diagnostics, data, and digital strategies, leading to faster drug launches and enhanced patient access.

Precision Oncology Paradigm Report

Explore how a companion diagnostic approach to precision oncology can reduce R&D costs and improve patient outcomes by efficiently targeting treatments to eligible patients.

Strategic Diagnostics in Action

Diaceutics accelerated gene therapy access by implementing a global strategy, reducing test result turnaround times from 28 days to 1 week and enhancing patient identification.

Strategies for Launch Success

Watch our Precision Medicine Webinar to explore strategies for successful therapy adoption and commercialization in the evolving precision medicine landscape.

Linking Rare Disease Patients to Targeted Therapies

Diaceutics connects rare disease patients to targeted therapies through advanced patient identification, improving access to care and accelerating clinical trial enrollment.

Episode 1: HRD Testing from Clinic to Lab

Discover insights on HRD from leading experts in the latest episode of the Better Testing, Better Treatment podcast, designed for clinicians and laboratory professionals.

Navigating Precision Commercialization

Explore innovative strategies for precision commercialization in biopharma. Learn how to enhance launch models and accelerate market adoption of targeted therapies.

ESMO 2025: Top 5 Key Cancer Diagnostics Takeaways From Our Experts

Discover 5 key insights from ESMO 2025 on cancer diagnostics, focusing on ctDNA, antibody-drug conjugates, and innovative strategies for improving patient outcomes in precision medicine.

Episode 2: Artificial Intelligence in Breast Cancer: from Clinic to Lab 

Explore how AI is transforming breast cancer diagnosis with insights from experts Dr. Elie Rassy and Dr. Magali Lacroix-Triki in this enlightening podcast episode.

CE-IVDR Report

Stay updated on the IVDR implementation and its impact on molecular testing, as experts share insights on challenges and future perspectives in the diagnostic landscape.

D-Cubed Full report 2025

Explore D-Cubed Pharma's comprehensive report on how Diagnostics, Data, and Digital transform pharma launch performance and patient access in 2026 and beyond.

Advancing Precision Medicine Adoption in the Asia-Pacific (APAC) Region

Explore strategies and recommendations to enhance precision medicine adoption in the APAC region, improving patient access to testing and treatment solutions.

Unlocking Diagnostic Clarity to Accelerate Market-Ready Strategy 

Unlock diagnostic clarity to drive market readiness, enhance adoption, and mitigate launch risks with tailored strategies and insights from Diaceutics. Connect to realize your therapy's potential.

The Operating Model Shaping Pharma’s Next Decade

Join industry leaders Peter Keeling and Rebecca Fryer as they discuss shaping the future of precision testing and commercialization in pharma during this insightful online event.

Delivering precision medicine success through a multi-year commercialization partnership

Discover how a global pharmaceutical leader successfully launched a first-in-class oncology therapy through strategic partnerships, accelerating testing readiness and driving adoption in precision medicine.

Episode 3: Targeted therapies in Gastric cancer: From clinic to labs  

Explore targeted therapies in gastric cancer through insights from a pathologist and oncologist in this episode of the Better Testing, Better Treatment podcast series.

Episode 4: Targeted therapies in cancer: From clinic to labs

Explore targeted cancer therapies from a European perspective in Episode 4 of the Better Testing, Better Treatment podcast, featuring insights from leading experts in the field.

Episode 5 Oncogenic Fusion detection and reporting in NSCLC and solid tumors

Explore the latest insights on oncogenic fusion detection and reporting in NSCLC and solid tumors from experts Dr. Solomon and Dr. Saxena in this informative podcast episode.

Episode 6 Artificial Intelligence in Prostate Cancer: from clinic to lab

Discover how AI enhances prostate cancer diagnostics and treatment in our podcast featuring experts Pr. Sophie Ferlicot and Dr. Mario Terlizzi.

Episode 7 Exploring Inherited Cancer: from clinic to lab

Discover how genetic testing for inherited cancer has evolved, transforming clinical practice and patient care, in episode 7 of the Better Testing, Better Treatment podcast.

Episode 8 The Pathology-Oncology Connection: Labs in Action

Explore how tailored testing and collaboration between labs and oncologists enhance diagnostic and treatment decisions in cancer care on the Better Testing, Better Treatment podcast.

Navigating the New Amendments to the EU In Vitro Devices Regulation (IVDR)

EU adopts amendments to the In Vitro Devices Regulation, extending compliance deadlines and addressing diagnostic shortages to support manufacturers and ensure availability of essential tools.

Precision Medicine Readiness Report 1

Read the first Precision Medicine Readiness Report, addressing diagnostic ecosystem challenges that hinder patient access and highlighting pharma's ongoing commercial readiness efforts.

Precision Medicine Readiness Report 2

In the second paper, discover how the Axis for Change manifesto aims to accelerate precision medicine testing from years to months, using NSCLC to highlight diagnostic flaws.

Precision Medicine Readiness Report 3

Explore the final report of the Axis for Change Manifesto, highlighting advancements in precision medicine and advocating for increased investment in diagnostic pathways for better patient access to treatments.

Why Commercial Strategy Must Step Up to Unlock Biomarker Testing and Actionability

Unlock the future of oncology with insights on biomarker testing, ADCs, ctDNA, and digital pathology trends shaping your commercial strategy. Stay competitive in precision medicine.

AI in Pharma Marketing, Diagnostics & the Future of Pharma Engagement

Discover how AI and real-time diagnostics data can transform pharma marketing, enhancing HCP engagement and driving better patient outcomes. Explore the future of pharma engagement today.

Q&A: How can a multi-modal approach using lab data simplify precision medicine?

Explore how a multi-modal approach using lab data enhances precision medicine, improving patient outcomes and treatment strategies through actionable insights and better-informed decisions.

Levelling Up series Part 2: Precision testing’s suboptimal HTA - Time to level up

Explore the need for improved economic assessments of precision testing to unlock the full potential of precision treatments in healthcare.

Speed to Market Starts Before the Prescription

Discover how Diaceutics and DeepIntent revolutionize pharma marketing by shifting focus to real-time diagnostic intelligence, enhancing engagement before prescriptions are written.

The Precision Medicine Webinar Series: Harnessing Real-World Data

Watch our second webinar in precision medicine series to explore data-driven strategies for therapy adoption, provider engagement, and improving patient outcomes in the evolving healthcare landscape.

Navigating Precision Medicine Challenges in IMIDs

Explore the challenges of diagnosing and treating immune-mediated inflammatory diseases, and discover how precision medicine can improve patient outcomes and streamline treatment strategies.

The Precision Medicine Webinar Series: Cutting through the noise in clinical education

Watch our third Precision Medicine Webinar with Gosia Leitch to explore data-driven strategies that enhance physician engagement and boost biomarker testing rates for successful therapy adoption.

The Precision Medicine Webinar Series: Accelerate Precision Medicine

Watch the last webinar in our Precision Medicine Series from 12th December, 2024, to explore strategies for improving biomarker adoption and optimizing therapeutic outcomes in the evolving healthcare landscape.

Levelling Up Series Part 3: The Systemic Shadow Hanging Over the Value of Diagnostics

Explore the critical need for improved measurement of diagnostics' value in precision medicine to drive innovation, reimbursement, and patient outcomes in healthcare.

Embracing Precision Medicine: The Heart of Value-Based Care

Discover how Diaceutics advances value-based care through precision medicine, ensuring patients receive tailored treatments supported by robust data integration and innovative solutions.

Unleashing the Potential of the Microbiome in Precision Medicine: A New Frontier for Pharma

Explore how the microbiome is transforming precision medicine, enhancing drug efficacy, and paving the way for innovative therapies in the pharmaceutical industry.

Reigniting Momentum: A Curated Round‑Up of This Season’s Most Impactful Insights

Discover how real-time diagnostic insights and expert-led engagement can rebuild prescriber confidence and reignite brand momentum.

Building the Pathway for a First-In-Class Oncology Launch

Discover how Diaceutics built a successful commercialization pathway for a first-in-class oncology therapy, enabling timely patient identification and physician engagement in a rare biomarker population.

Join us at Fierce Pharma Week

Join us at Fierce Pharma Week to explore innovative diagnostic-driven therapy commercialization strategies. Engage with experts and discover how real-world data can enhance HCP engagement.

We're attending Fierce Pharma Week